Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Elisabetta, Massara"'
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 6, Iss 9, p 85 (2017)
Journal of Clinical Medicine, Vol 6, Iss 9, p 85 (2017)
Von Willebrand disease (VWD) is the most frequent inherited bleeding disorder and is caused by either a quantitative and/or qualitative defect of the multimeric glycoprotein vonWillebrand factor (VWF).[...]
Autor:
Francesca Luise, Giuseppe Irrera, Tiziana Moscato, Massimo Martino, Corrado Mammì, Elisabetta Massara, Carmelo Laganà, Vincenzo Oriana, Giuseppe Messina, Vincenzo Trapani Lombardo, Giuseppe Console, Angela Piromalli, Pasquale Iacopino
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
Scopus-Elsevier
The aim of the study was to verify the utility of the clinical practice of administering thrombophilic screening and antithrombotic prophylaxis with low-molecular-weight heparin to healthy donors receiving granulocyte colony-stimulating factor to mob
Autor:
Pasquale Iacopino, Giuseppe Console, Caterina Stelitano, Fortunato Morabito, Giuseppe Messina, Massimo Martino, Elisabetta Massara, Vincenzo Callea, Giuseppe Irrera
Publikováno v:
European Journal of Haematology. 78:35-40
Although a double autologous peripheral blood stem cell transplant (APBSCT) is an effective therapy for patients (pts) with multiple myeloma and extends progression-free survival and overall survival, pts show a continued pattern of recurrent disease
Autor:
Massimo Martino, Giulia Praticò, Giuseppe Messina, Giuseppe Irrera, Elisabetta Massara, Giuseppe Console, Pasquale Iacopino
Publikováno v:
European Journal of Haematology. 77:410-415
We undertook a comparative study of Pegfilgrastim vs. Filgrastim after high-dose melphalan and autologous peripheral blood stem cell transplantation (APBSCT) in multiple myeloma (MM) patients. Thirty-seven consecutive patients were randomly assigned
Autor:
Luana Calabrò, Domenica Gangemi, Eugenia Quartarone, Elisabetta Massara, Andrea Alonci, Giacomo Bellomo, Caterina Musolino, Barbara Loteta
Publikováno v:
European Journal of Haematology. 72:416-419
Angiogenesis is critical for the clinical progression of haematopoietic malignancies and depends on angiogenic factors. Angiogenin is a powerful factor produced by neoplastic cells and host microenvironment. High levels of soluble angiogenin (sAng) c
Autor:
Elisabetta Massara, Tiziana Moscato, Giuseppe Cornelio, Giulia Ressa, Lucrezia Imbalzano, Giuseppe Bresolin, Roberta Fedele, Massimo Martino
Publikováno v:
Expert opinion on biological therapy. 12(8)
Extracorporeal photopheresis (ECP) has been extensively used for the treatment of immune-mediated diseases for over 20 years and has a consistent and predictable safety profile with long-term use. Documenting the efficacy of ECP as therapeutic treatm
Autor:
Anna Grazia Recchia, Massimo Martino, Elisabetta Massara, Roberta Fedele, Giuseppe Irrera, Fortunato Morabito
Publikováno v:
Expert opinion on biological therapy. 12(5)
Granulocyte colony-stimulating factor (G-CSF) is a hematopoietic growth factor that stimulates the proliferation and differentiation of neutrophil precursor cells. G-CSF-mobilized peripheral blood (PB) hematopoietic progenitor stem cells (HPSCs) coll
Autor:
Roberta, Fedele, Massimo, Martino, Cristina, Garreffa, Giuseppe, Messina, Giuseppe, Console, Domenica, Princi, Antonella, Dattola, Tiziana, Moscato, Elisabetta, Massara, Elisa, Spiniello, Giuseppe, Irrera, Pasquale, Iacopino
Publikováno v:
Blood transfusion = Trasfusione del sangue. 10(2)
Different factors influence the clinical outcome of allogeneic transplants, the foremost being good immune recovery.The purpose of this study was to evaluate the influence of different factors, such as stem cell source, type of donor, conditioning re
Autor:
Caterina, Musolino, Andrea, Alonci, Giacomo, Bellomo, Barbara, Loteta, Eugenia, Quartarone, Domenica, Gangemi, Elisabetta, Massara, Luana, Calabrò
Angiogenesis is critical for the clinical progression of haematopoietic malignancies and depends on angiogenic factors. Angiogenin is a powerful factor produced by neoplastic cells and host microenvironment. High levels of soluble angiogenin (sAng) c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5046a0af63ec02fe56fe86e371775935
http://hdl.handle.net/11392/2492553
http://hdl.handle.net/11392/2492553
Autor:
Grazia Pellicano, Massimo Martino, Rosalba Di Filippo Scali, Giuseppe Irrera, Tiziana Moscato, Giuseppe Console, Letteria Russo, Giuseppe Messina, Roberta Fedele, Elisabetta Massara
Publikováno v:
Blood. 118:4497-4497
Abstract 4497 BACKGROUND: After high-dose melphalan with autologous peripheral hematopoietic stem cell transplantation (APHSCT) long hospital stays in the aplastic phase are expensive, lead to increased risk of hospital infections and to increasing p